Orange Book product · Generic (ANDA)
FONDAPARINUX SODIUM
FONDAPARINUX SODIUM
At a glance
May 15, 2018
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 15, 2018
8 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
FONDAPARINUX SODIUM
Strength
2.5MG/0.5ML (2.5MG/0.5ML)
Dosage form
SOLUTION
Route
SUBCUTANEOUS
TE code
AP
Application
ANDA 206812
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FONDAPARINUX SODIUM
- 2001ARIXTRABrand (NDA)
NDA 021345 · MYLAN IRELAND LTD
- 2024FONDAPARINUX SODIUMGeneric (ANDA)
ANDA 218312 · BRIGHTGENE
- 2024FONDAPARINUX SODIUMGeneric (ANDA)
ANDA 216493 · HANGZHOU ZHONGMEI
- 2018FONDAPARINUX SODIUMGeneric (ANDA)
ANDA 208615 · SCINOPHARM TAIWAN
- 2017FONDAPARINUX SODIUMGeneric (ANDA)
ANDA 206918 · EUGIA PHARMA
- 2011FONDAPARINUX SODIUMGeneric (ANDA)
ANDA 091316 · DR REDDYS LABS LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
